Routine Laboratory Biomarkers As Prognostic Indicators of Cardiac Sarcoidosis Outcomes

BACKGROUND: Biomarkers to monitor disease activity and predict major adverse cardiac events (MACE) in CS have not been described previously. We aimed to identify biomarkers to predict MACE in cardiac sarcoidosis (CS). METHODS: Patients (N=232) diagnosed with CS were retrospectively enrolled. Biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolluri, Nikhil, Schmidt, Tyler J., Elwazir, Mohamed Y., Kapa, Suraj, Abou Ezzeddine, Omar F., Bois, John P., Schirger, John A., Rosenbaum, Andrew N., Cooper, Leslie T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2022
Materias:
Original Article: Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766851/
https://www.ncbi.nlm.nih.gov/pubmed/36791034
http://dx.doi.org/10.36141/svdld.v39i2.11136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766851/
https://www.ncbi.nlm.nih.gov/pubmed/36791034
http://dx.doi.org/10.36141/svdld.v39i2.11136

Ejemplares similares